Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Orkla ASA (ORK.OL)
Oslo, NO
Orkla ASA, a company based in Oslo, Norway, functions as a diversified conglomerate with core activities in branded consumer goods, industrial ventures, and financial investments. Its expansive portfolio of consumer products encompasses a wide range of food items, such as frozen pizzas, ketchups, various soups and sauces, bread toppings, and ready-to-eat meals. These are distributed through numerous channels, including grocery retailers, the out-of-home sector, convenience stores, and petrol stations. Additionally, Orkla produces confectionery, biscuits, snacks, crispbread products, and energy snack meals. Beyond edibles, the company manufactures personal care and cleaning solutions, dietary supplements, sports nutrition, and weight management products. Its offerings further extend to wound care items, first aid equipment, painting tools, essential garments, and professional cleaning supplies. Complementing its manufacturing operations, Orkla manages e-commerce platforms like Gymgrossisten and Bodystore, specializing in health and sports nutrition products, and also operates a chain of restaurants. On the industrial side, the company is a key supplier of food ingredients, including margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and components for ice cream. Furthermore, Orkla is involved in generating and supplying hydropower to the Nordic energy market and actively engages in real estate development and sales. The company markets its diverse food products under well-known brands such as Grandiosa, TORO, Stabburet, Felix, Paulúns, Abba, Kalles, Beauvais, Den Gamle Fabrik, Spilva, Vitana, MTR, and Eastern. Its confectionery and snack range includes popular names like KiMs, Nidar, Stratos, Göteborgs Kex, Sætre, OLW, Panda, Laima, Selga, Taffel, Adazu, and Kalev. Health, personal care, and cleaning items are offered through brands such as Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick. Key food ingredient brands include Odense, Mors Hjemmebakte, KronJäst, Bakkedal, and NATURLI'. Orkla maintains a significant operational footprint across Norway, Sweden, Denmark, Finland, Iceland, the Baltic states, the wider European continent, and other international markets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.94% | -2.09% | -10.47% | -17.22% | +3.16% | -4.01% | -6.02% | +31.21% | +27.76% | +43.89% | +284.64% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 6 | +1 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+1.3% Q1'26: +1.3% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%+89.4% ★ Q1'26: -4.5% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+10.1% Q1'26: +7.5% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+12.9% ★ Q1'26: +13.2% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+11.4% ★ Q1'26: +11.7% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%-0.1% ★ Q1'26: -1.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×1.40× Q1'26: 1.60× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 6 EPS Ana. |
Dec 2027 7 Rev. Ana. 6 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
30.06B
est: 62.95B (-52.2%)
|
24.60B
est: 30.09B (-18.3%)
|
28.02B
est: 33.36B (-16.0%)
|
29.60B
est: 32.05B (-7.6%)
|
33.20B
est: 32.90B (+0.9%)
|
37.76B
est: 37.82B (-0.2%)
|
39.56B
est: 39.29B (+0.7%)
|
40.84B
est: 40.84B (0.0%)
|
43.62B
est: 43.43B (+0.4%)
|
47.14B
est: 47.23B (-0.2%)
|
50.44B
est: 50.03B (+0.8%)
|
58.39B
est: 57.87B (+0.9%)
|
67.80B
est: 68.87B (-1.6%)
|
70.66B
est: 70.16B (+0.7%)
|
71.55B
est: 71.37B (+0.3%)
|
73.02B
70.49B – 74.56B
+2.3% YoY
|
75.52B
72.30B – 77.54B
+3.4% YoY
|
78.14B
77.85B – 78.44B
+3.5% YoY
|
79.29B
76.22B – 81.19B
+1.5% YoY
|
82.08B
78.91B – 84.05B
+3.5% YoY
|
| EBITDA |
7.18B
est: -1.55B (+563.0%)
|
5.50B
est: -702.33M (+883.7%)
|
4.82B
est: 4.86B (-0.8%)
|
4.17B
est: 3.29B (+26.8%)
|
5.53B
est: 3.31B (+67.1%)
|
5.76B
est: 7.14B (-19.3%)
|
6.20B
est: 7.10B (-12.6%)
|
5.80B
est: 11.54B (-49.7%)
|
7.39B
est: 5.89B (+25.6%)
|
8.00B
est: 8.14B (-1.7%)
|
8.68B
est: 8.33B (+4.1%)
|
10.18B
est: 8.56B (+18.9%)
|
11.06B
est: 11.83B (-6.5%)
|
12.86B
est: 10.43B (+23.3%)
|
11.96B
est: 12.26B (-2.5%)
|
12.54B
12.10B – 12.80B
+2.3% YoY
|
12.97B
12.42B – 13.32B
+3.4% YoY
|
13.42B
13.37B – 13.47B
+3.5% YoY
|
13.62B
13.09B – 13.94B
+1.5% YoY
|
14.10B
13.55B – 14.43B
+3.5% YoY
|
| EBIT |
5.05B
est: 4.21B (+20.0%)
|
4.54B
est: 1.41B (+222.5%)
|
3.28B
est: 3.18B (+2.8%)
|
3.20B
est: 2.19B (+45.9%)
|
4.37B
est: 3.25B (+34.7%)
|
4.60B
est: 3.56B (+29.1%)
|
4.87B
est: 4.08B (+19.4%)
|
4.53B
est: 4.61B (-1.7%)
|
5.17B
est: 4.57B (+13.2%)
|
5.55B
est: 4.87B (+14.1%)
|
6.59B
est: 4.98B (+32.2%)
|
7.77B
est: 5.12B (+52.0%)
|
8.07B
est: 8.86B (-8.9%)
|
9.30B
est: 9.03B (+3.0%)
|
9.22B
est: 9.18B (+0.4%)
|
9.39B
9.07B – 9.59B
+2.3% YoY
|
9.72B
9.30B – 9.98B
+3.4% YoY
|
10.05B
10.02B – 10.09B
+3.5% YoY
|
10.20B
9.81B – 10.45B
+1.5% YoY
|
10.56B
10.15B – 10.81B
+3.5% YoY
|
| Net Income |
-756.00M
est: -914.54M (+17.3%)
|
1.63B
est: -370.50M (+541.0%)
|
690.00M
est: 1.77B (-61.0%)
|
1.66B
est: 662.95M (+150.2%)
|
3.30B
est: 1.73B (+90.5%)
|
4.29B
est: 3.78B (+13.6%)
|
8.58B
est: 4.47B (+92.0%)
|
3.27B
est: 8.91B (-63.3%)
|
3.84B
est: 3.48B (+10.3%)
|
4.37B
est: 4.13B (+5.9%)
|
4.81B
est: 4.22B (+13.8%)
|
5.02B
est: 4.34B (+15.7%)
|
5.20B
est: 6.06B (-14.2%)
|
6.06B
est: 6.36B (-4.7%)
|
11.47B
est: 6.35B (+80.6%)
|
6.53B
6.29B – 7.36B
+2.8% YoY
|
7.03B
6.78B – 7.93B
+7.6% YoY
|
7.43B
6.83B – 8.77B
+5.7% YoY
|
7.97B
7.57B – 8.22B
+7.3% YoY
|
8.65B
8.22B – 8.92B
+8.5% YoY
|
| SGA |
2.42B
est: 11.80B (-79.5%)
|
2.06B
est: 5.69B (-63.7%)
|
2.20B
est: 7.38B (-70.2%)
|
2.32B
est: 7.51B (-69.1%)
|
2.45B
est: 7.95B (-69.2%)
|
2.74B
est: 9.46B (-71.0%)
|
2.83B
est: 3.15B (-10.2%)
|
2.94B
est: 9.92B (-70.4%)
|
3.24B
est: 10.35B (-68.8%)
|
3.53B
est: 10.63B (-66.8%)
|
4.01B
est: 10.88B (-63.2%)
|
4.77B
est: 11.17B (-57.3%)
|
5.45B
est: 4.49B (+21.4%)
|
5.97B
est: 4.57B (+30.5%)
|
—
est: 4.65B (-100.0%)
|
4.76B
4.60B – 4.86B
+2.3% YoY
|
4.92B
4.71B – 5.06B
+3.4% YoY
|
5.09B
5.08B – 5.11B
+3.5% YoY
|
5.17B
4.97B – 5.29B
+1.5% YoY
|
5.35B
5.14B – 5.48B
+3.5% YoY
|
| EPS |
-0.70
est: 4.30 (-116.3%)
|
1.61
est: 2.72 (-40.9%)
|
0.68
est: 2.61 (-74.0%)
|
1.63
est: 2.40 (-32.0%)
|
3.24
est: 3.20 (+1.4%)
|
4.22
est: 3.97 (+6.3%)
|
8.43
est: 3.71 (+127.3%)
|
3.24
est: 3.68 (-12.1%)
|
3.84
est: 3.88 (-1.1%)
|
4.37
est: 4.80 (-8.9%)
|
4.82
est: 5.05 (-4.6%)
|
5.04
est: 5.43 (-7.1%)
|
5.21
est: 6.07 (-14.2%)
|
6.07
est: 6.42 (-5.5%)
|
11.51
est: 6.40 (+79.7%)
|
6.78
6.30 – 7.37
+5.8% YoY
|
7.23
6.79 – 7.94
+6.7% YoY
|
7.72
6.84 – 8.78
+6.8% YoY
|
7.98
7.58 – 8.23
+3.3% YoY
|
8.66
8.22 – 8.93
+8.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-13 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-12 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-08 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-07 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-06 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-05 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-04 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-30 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-29 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-28 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-27 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-24 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-15 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Nils Kloumann Selte | President & Chief Executive Officer | 23M | male |
| Arve Regland | EVP & CFO | 8M | male |
| Christer Gronberg | Head of Corporate Functions | 7M | male |
| Maria Syse-Nybraaten | Executive Vice President of Investments | 7M | female |
| Oyvind Torpp | Executive Vice President of Investments | 7M | male |
| Audun Stensvold | Executive Vice President of Investments | 7M | male |
| Hege Holter Brekke | Executive Vice President of Investments | 7M | female |
| Camilla Tellefsdal Robstad | Executive Vice President of Legal & Compliance | 6M | female |
| Karl Otto Tveter | Lawyer & Adviser | 4M | male |
| Thomas Ljungqvist | Chief Executive Officer of Orkla Financial Investment | — | male |
| Dag Olav Stokken | Senior Vice President of Communications | — | — |
| Daniel Stenberg | Chief Operating Officer of Orkla Care | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ORK.OL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
